Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by palinc2000on Jul 07, 2022 5:30pm
133 Views
Post# 34809674

RE:RE:Investors matter

RE:RE:Investors matter

For sure the company knows more than we do.Should they disclose exactly what they know.?
I dont think so.They know more but they dont know enough yet to draw definite conclusions .When they are able to confirm efficacy they will tell us....
The mere fact that the trial is still on going is a positive...
I have seen biotechs in the past raise a lot of hopes in preliminary findings that ended up being anecdotal and never confirmed....

How much more time is needed ? I certainly dont know  ....how fast will they recruit patients in the basket trial? We dhould know next week how many have been recruited so far but I dont expect much more info on the trial.....

<< Previous
Bullboard Posts
Next >>